This Month in Psychopharmacology

Blood Test Predicts Which People With Amyloid Are Likely to Decline Cognitively

The pathology of Alzheimer’s disease (AD) begins with a prolonged p...

Read More

'Convincing Evidence' Hearing Aids Reduce Dementia Risk

With no truly effective treatment for dementia yet available, there...

Read More

Association Between Consumption of Ultraprocessed Foods and Cognitive Decline

In a recent cohort study, the relationship benzodiazepines versus a...

Read More

FDA Authorizes Marketing for New Test to Improve Diagnosis of Alzheimer’s Disease

The U.S. Food and Drug Administration (FDA) approved marketing auth...

Read More

Impact of Neuropsychiatric Symptoms in Alzheimer’s Disease

Neuropsychiatric symptoms, including depression, apathy, and anxiet...

Read More

5-HT4-Receptor Agonists May Boost Cognitive Impairments Associated With Psychiatric Disorders

Many psychiatric disorders include symptoms of cognitive impairment...

Read More

ADHD and Alzheimer’s Disease Across Generations

Due to previous conflicting results regarding the association betwe...

Read More

Histamine 3 Receptor Inverse Agonist For Cognitive Disorders

istamine H3 receptors, found throughout the cortex and hippocampus,...

Read More

Systolic Orthostatic Hypotension Tied to Dementia Risk

A recent study examined whether orthostatic hypotension and visit-t...

Read More

Biogen Submits Application for US Approval for Alzheimer Drug

Biogen completed the submission of a Biologics License Application ...

Read More

Pointing a Finger at Parkinson's Disease Dementia

As many as 80% of patients with Parkinson's disease develop dementi...

Read More

Ex-NFL Player Confirmed as First Case of Chronic Traumatic Encephalopathy in Living Patient

New research appears to confirm that positron emission tomography (...

Read More